Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akili, Inc. - Common Stock (NQ: AKLI )

0.5499 +0.0041 (+0.75%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,210
Open 0.5500
Bid (Size) 0.5200 (10)
Ask (Size) 0.6000 (1)
Prev. Close 0.5458
Today's Range 0.5350 - 0.6100
52wk Range 0.5252 - 2.760
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Performance

YTD
-50.01%
-50.01%
1 Month
-41.90%
-41.90%
3 Month
-52.18%
-52.18%
6 Month
-66.26%
-66.26%
1 Year
-77.56%
-77.56%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Akili Announces Business Transformation, Focusing on Non-prescription Model
From Akili, Inc.
Via Business Wire
Akili Reports Second Quarter 2023 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults
Via Benzinga
Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD
From Akili, Inc.
Via Business Wire
Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress
From Akili, Inc.
Via Business Wire
Akili Reports First Quarter 2023 Financial Results and Provides Business Update
From Akili, Inc.
Via Business Wire
Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From PureTech Health plc
Via Business Wire
Game-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioning
Via Benzinga
RIVN Stock Alert: Rivian Preps for Georgia Manufacturing Facility
Via InvestorPlace
Why Is Akili (AKLI) Stock Up 21% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From Akili, Inc.
Via Business Wire
Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET
From Akili, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.